ATTO — Attovia Therapeutics, Inc.

Nasdaq · Health Care · Biotechnology · CIK 2058707 ·
Last close
$19.86
Market Cap
52W High
$22.79
52W Low
$16.15
ADV30
1,006,229
Next earnings

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -19,955,000 -18,656,000 146,086,000 43,297,000 271,601,000
Mar 2025 0 -16,104,000 -15,151,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-32,272,000
Investing CF
$-6,808,000
Financing CF
$140,653,000
CapEx
$-2,080,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.33
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-129,666,000
Inventory
Receivables
$700,000
ST Investments
$89,325,000
EBIT TTM
$-36,059,000
Pretax Income TTM
$-33,807,000
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,350,000 -67,159,000 -60,627,000 165,893,000 273,329,000 -59,199,000
Dec 2024 0 -41,553,000 -39,801,000 76,716,000 123,541,000 -35,035,000

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $224.09B $415.21
GILD GILEAD SCIENCES, INC. $171.56B $138.36
ARGX ARGENX SE $53.26B $851.29
RVMD Revolution Medicines, Inc. $43.66B $203.71
BIIB BIOGEN INC. $31.00B $209.83

News headlines (Yahoo Finance, 1h cache)

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
2026-08-06 09:57 · Yahoo
Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2026-08-06 20:05 · Yahoo
Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
2026-08-05 00:50 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.